Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness,” published in the November 2024 issue ...

COVID-19, influenza, and respiratory syncytial virus vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).

点击上方“感染学苑” 掌握感染疾病前沿动态9月26日，首都医科大学附属北京儿童医院、国家儿童医学中心、国家呼吸疾病临床研究中心、国家肿瘤监测中心倪鑫教授团队在《The New England Journal of ...

Approximately 1 in 20 adults with outpatient respiratory syncytial virus (RSV) infections were readmitted to the hospital ...

When should pregnant women get the RSV vaccine? Research suggests that 32 weeks into pregnancy ensures the best antibody ...

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

Seasonal maternal respiratory syncytial virus vaccination and nirsevimab for infants demonstrate cost-effectiveness.

PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced new preliminary data for AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) in adults aged 18-49 at increased risk for ...

The "Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. "Respiratory Syncytial Virus (RSV)- Pipeline Insight, 2024" report ...

The Centers for Disease Control and Prevention said on Wednesday it expects to see an increase in levels of COVID-19 and ...